Re-I Chin

Dr. Re-I Chin

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2017 in Cancer
Verified
Journal Article
Closed access
PDF file
BMBindu V. Manyam
Bindu V. Manyam
AGAdam A. Garsa
Adam A. Garsa
RCRe-I Chin
Re-I Chin
CRChandana A. Reddy
Chandana A. Reddy
BGBrian Gastman
Brian Gastman
SKShlomo A. Koyfman
Shlomo A. Koyfman

10 August 2013 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
XCXiaoqing Chen
Xiaoqing Chen
SPSharad C. Paudyal
Sharad C. Paudyal
RCRe-I Chin
Re-I Chin
ZYZhongsheng You
Zhongsheng You
Exo1-mediated resection of DNA double-strand break ends generates 3′ single-stranded DNA overhangs required for homology-based DNA repair and activation of the ATR-dependent checkpoint. Despite its critical importance in inducing the overall DNA damage response, the mechanisms and regulation of the Exo1 resection pathway remain incompletely understood. Here, we identify the ring-shaped DNA clamp PCNA as a new factor in the Exo1 resection pathway. Using mammalian cells, Xenopus nuclear extracts and purified proteins, we show that after DNA damage, PCNA loads onto double-strand breaks and promotes Exo1 damage association through direct interaction with Exo1. By tethering Exo1 to the DNA substrate, PCNA confers processivity to Exo1 in resection. This role of PCNA in DNA resection is analogous to its function in DNA replication where PCNA serves as a processivity co-factor for DNA polymerases.

1 March 2022 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
RCRe-I Chin
Re-I Chin
ARAmit Roy
Amit Roy
KPKatrina S. Pedersen
Katrina S. Pedersen
YHYi Huang
Yi Huang
SHSteven R. Hunt
Steven R. Hunt
HKHyun Kim
Hyun Kim

5 September 2022 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
JSJoshua P. Schiff
Joshua P. Schiff
APAlex T. Price
Alex T. Price
HSHayley B. Stowe
Hayley B. Stowe
ELEric Laugeman
Eric Laugeman
RCRe-I Chin
Re-I Chin
LHLauren E. Henke
Lauren E. Henke

7 September 2017 in Cancer
Verified
Journal Article
Open access
PDF file
RCRe-I Chin
Re-I Chin
YRYuan J. Rao
Yuan J. Rao
MHMichael Y. Hwang
Michael Y. Hwang
CSChristopher R. Spencer
Christopher R. Spencer
MPMichael Pierro
Michael Pierro
WTWade L. Thorstad
Wade L. Thorstad
BACKGROUND: The authors hypothesized that unilateral intensity‐modulated radiotherapy (IMRT) would decrease toxicity compared with bilateral IMRT for patients with lateralized palatine tonsillar cancer and a neck classification of N0 to N2b, with similar oncological outcomes.METHODS: A total of 154 patients were treated with postoperative IMRT from 1997 through 2013. Data were collected prospectively from 2005 to 2013 and retrospectively collected before 2005. Of those patients with lateralized primary and N0 to N2b disease, 48 received unilateral IMRT (group 1) and 59 received bilateral IMRT (group 2); a total of 47 patients had nonlateralized primary or N2c to N3 disease and received bilateral IMRT (group 3).RESULTS: The median follow‐up was 5.5 years. The 5‐year locoregional control rates were similar in group 1, group 2, and group 3 (100%, 96%, and 94%, respectively; pooled comparison: P = .39 and group 1 vs group 2 comparison: P = .19). The 5‐year overall survival rates were similar in group 1, group 2, and group 3 (85%, 79%, and 76%, respectively; pooled comparison: P = .60 and group 1 vs group 2 comparison: P = .25). There were no contralateral neck recurrences noted among unilaterally treated patients. Unilateral IMRT reduced acute toxicity and improved patient‐reported quality of life compared with bilateral IMRT.CONCLUSIONS: Unilateral IMRT appears to reduce acute toxicity and achieves oncological outcomes similar to those of bilateral IMRT in selected patients with lateralized palatine tonsillar cancer with a neck classification of N0 to N2b. Cancer 2017;123:4594‐4607. © 2017 American Cancer Society.

1 September 2021 in Clinical Colorectal Cancer
Verified
Journal Article
Closed access
HKHyun Kim
Hyun Kim
KPKatrina S Pedersen
Katrina S Pedersen
JOJeffrey R. Olsen
Jeffrey R. Olsen
MMMatthew G. Mutch
Matthew G. Mutch
RCRe-I Chin
Re-I Chin
SHSteven R. Hunt
Steven R. Hunt